Cormedix
CRMD
$5.30
Share price
2.51%
Change (1 day)
2.32%
Change (1 year)
Categories
Cormedix (CRMD) - P/B ratio
P/B ratio as of May 2024 : 4.05
According to Cormedix's latest financial reports the company has a price-to-book ratio of 4.05.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Cormedix - P/B ratio (from 2010 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.94 | -7.14% |
| 2022-12-31 | 3.16 | 14.66% |
| 2021-12-31 | 2.76 | -48.88% |
| 2020-12-31 | 5.40 | -31.68% |
| 2019-12-31 | 7.90 | -72.24% |
| 2018-12-31 | 28.5 | 508.54% |
| 2017-12-31 | 4.68 | 34.72% |
| 2016-12-31 | 3.47 | 61.75% |
| 2015-12-31 | 2.15 | -81.82% |
| 2014-12-31 | 11.8 | -330.57% |
| 2013-12-31 | -5.12 | -79.1% |
| 2012-12-31 | -24.5 | -1112.53% |
| 2011-12-31 | 2.42 | -15.45% |
| 2010-12-31 | 2.86 | |
| 2009-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | 2.69 | -33.66% | 🇺🇸 USA |
 Utah Medical Products UTMD | 1.92 | -52.56% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 0.3511 | -91.34% | 🇺🇸 USA |